Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -795.50% is 268% below its 5-year average of -216.05%, near the high end of its 5-year range (-6595.52%–0.00%).
11.59% above its 12-month average of -899.76%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -606.50%.
NET PROFIT MARGIN
-795.50%
NET PROFIT MARGIN AVG TTM
-899.76%
NET PROFIT MARGIN AVG 3Y
-526.02%
NET PROFIT MARGIN AVG 5Y
-216.05%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+11.59%
CURRENT VS 3Y AVG
-51.23%
CURRENT VS 5Y AVG
-268.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
SeaStar Medical Holding Corporation
Market Cap
$9.17M
Net Profit Margin
-795.50%
TTM Avg
-899.76%
3Y Avg
-526.02%
5Y Avg
-216.05%
Market Cap
$9.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.29M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.80M
Net Profit Margin
-106283.32%
TTM Avg
-41799.65%
3Y Avg
-23818.56%
5Y Avg
-17447.75%
Market Cap
$8.53M
Net Profit Margin
-66.29%
TTM Avg
-59.63%
3Y Avg
-44.17%
5Y Avg
-31.01%
Market Cap
$10.07M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$8.24M
Net Profit Margin
-1100.30%
TTM Avg
-235.88%
3Y Avg
-120.03%
5Y Avg
-120.03%
Market Cap
$10.18M
Net Profit Margin
-71.51%
TTM Avg
-193.27%
3Y Avg
-1708.98%
5Y Avg
-2188.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.17M | -795.50% | -899.76% | -526.02% | -216.05% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| MetaVia Inc. (MTVA)vs › | $9.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ainos, Inc. (AIMD)vs › | $9.80M | -106283.32% | -41799.65% | -23818.56% | -17447.75% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | -66.29% | -59.63% | -44.17% | -31.01% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.24M | -1100.30% | -235.88% | -120.03% | -120.03% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.18M | -71.51% | -193.27% | -1708.98% | -2188.03% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | 0.00% | -431.21% | -828.00% | -552.00% |
Operating Margin
-986.6%
Net Profit Margin
-795.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -606.50% |
| 2026-03-31 | -711.31% |
| 2025-12-31 | -691.43% |
| 2025-09-30 | -1897.27% |
| 2025-06-30 | -592.31% |
| 2025-03-31 | -1287.37% |
| 2024-12-31 | -6595.52% |
| 2024-09-30 | -6585.29% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |